Cargando…

Survival outcomes and efficacy of autologous CD19 chimeric antigen receptor-T cell therapy in the patient with diagnosed hematological malignancies: a systematic review and meta-analysis

Purpose: Chimeric Antigen Receptor T(CAR-T) cell therapy is an immunotherapy approach used in treating cancer which has seen rapid development over the decades. It becomes the preferred treatment choice after patients have failed conventional chemotherapy. Methods: We conducted a meta-analysis in 32...

Descripción completa

Detalles Bibliográficos
Autores principales:	Drokow, Emmanuel Kwateng, Ahmed, Hafiz Abdul Waqas, Amponsem-Boateng, Cecilia, Akpabla, Gloria Selorm, Song, Juanjuan, Shi, Mingyue, Sun, Kai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511615/ https://www.ncbi.nlm.nih.gov/pubmed/31190844 http://dx.doi.org/10.2147/TCRM.S203822

Ejemplares similares

Circulating microRNA as diagnostic biomarkers for haematological cancers: a systematic review and meta-analysis
por: Drokow, Emmanuel Kwateng, et al.
Publicado: (2019)

The Impact of Video-Based Educational Interventions on Cervical Cancer, Pap Smear and HPV Vaccines
por: Drokow, Emmanuel Kwateng, et al.
Publicado: (2021)

Prognostic Variables of Younger-Aged Cervical Carcinoma Patients: A Retrospective Study
por: Drokow, Emmanuel Kwateng, et al.
Publicado: (2021)

Tolerability, Efficacy and Feasibility of Concurrent Gemcitabine and Cisplatin (CGP) Combined With Intensity Modulated Radiotherapy for Loco-Regionally Advanced Carcinoma of the Cervix
por: Drokow, Emmanuel Kwateng, et al.
Publicado: (2020)

Awareness of Cervical Cancer and Attitude Toward Human Papillomavirus and Its Vaccine Among Ghanaians
por: Drokow, Emmanuel Kwateng, et al.
Publicado: (2020)

Chimeric antigen T cell receptor treatment in hematological malignancies
por: Ali, Natasha
Publicado: (2019)

Eltrombopag Effectiveness and Tolerability in Chronic Immune Thrombocytopenia: A Meta-Analysis
por: Ahmed, Hafiz Abdul Waqas, et al.
Publicado: (2021)

Application of Chimeric Antigen Receptor T Cells in the Treatment of Hematological Malignancies
por: Yan, Weiqi, et al.
Publicado: (2020)

Chimeric Antigen Receptor T Cell Therapy in Hematology
por: Ataca, Pınar, et al.
Publicado: (2015)

Chimeric Antigen Receptor T Cell Exhaustion during Treatment for Hematological Malignancies
por: Shen, Chunyi, et al.
Publicado: (2020)

Clinical development of chimeric antigen receptor-T cell therapy for hematological malignancies
por: Yang, Zhihuan, et al.
Publicado: (2023)

Chimeric antigen receptor T (CAR‐T) cells: Novel cell therapy for hematological malignancies
por: Abbasi, Samane, et al.
Publicado: (2022)

Evaluating and monitoring bone marrow hypoplasia in adults with aplastic anemia via high-resolution iliac magnetic resonance imaging in the current era
por: Yang, Xiawan, et al.
Publicado: (2019)

The synergistic antileukemic effects of eltrombopag and decitabine in myeloid leukemia cells
por: Shi, Mingyue, et al.
Publicado: (2019)

Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance
por: Boyiadzis, Michael M., et al.
Publicado: (2018)

Preclinical and clinical advances in dual‐target chimeric antigen receptor therapy for hematological malignancies
por: Guo, Zhenling, et al.
Publicado: (2021)

Strategies to optimize chimeric antigen receptor T-cell therapy in hematologic malignancies: Chinese experience
por: Sun, Wei, et al.
Publicado: (2023)

High blood pressure among adolescents in Africa: A systematic review and meta-analysis protocol
por: Amponsem-Boateng, Cecilia, et al.
Publicado: (2022)

Chimeric antigen receptor T cells self-neutralizing IL6 storm in patients with hematologic malignancy
por: Xue, Lei, et al.
Publicado: (2021)

Strategies for Reducing Toxicity and Enhancing Efficacy of Chimeric Antigen Receptor T Cell Therapy in Hematological Malignancies
por: Wang, Haobing, et al.
Publicado: (2023)

Chimeric antigen receptor T‑cell therapy—a hematological success story
por: Wohlfarth, Philipp, et al.
Publicado: (2018)

Current Status and Perspectives of Dual-Targeting Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Hematological Malignancies
por: Xie, Bailu, et al.
Publicado: (2022)

Cardiotoxicity Associated With Chimeric Antigen Receptor (CAR)-T Cell Therapy for Hematologic Malignancies: A Systematic Review
por: Hanna, Kerollos S, et al.
Publicado: (2022)

Chimeric Antigen Receptor T-cell Therapy in Hematologic Malignancies and Patient-reported Outcomes: A Scoping Review
por: Efficace, Fabio, et al.
Publicado: (2022)

CD38 as a pan-hematologic target for chimeric antigen receptor T cells
por: Glisovic-Aplenc, Tina, et al.
Publicado: (2023)

LSD1 as a Biomarker and the Outcome of Its Inhibitors in the Clinical Trial: The Therapy Opportunity in Tumor
por: Agboyibor, Clement, et al.
Publicado: (2021)

Chimeric Antigen Receptor-T-Cell Therapy for B-Cell Hematological Malignancies: An Update of the Pivotal Clinical Trial Data
por: Roex, Gils, et al.
Publicado: (2020)

The Role of Chimeric Antigen Receptor-T Cell Therapy in the Treatment of Hematological Malignancies: Advantages, Trials, and Tribulations, and the Road Ahead
por: Rohit Reddy, Sai, et al.
Publicado: (2021)

Recent findings on chimeric antigen receptor (CAR)-engineered immune cell therapy in solid tumors and hematological malignancies
por: Keshavarz, Ali, et al.
Publicado: (2022)

Polymorphism in the Androgen Biosynthesis Gene (CYP17), a Risk for Prostate Cancer: A Meta-Analysis
por: Effah, Clement Yaw, et al.
Publicado: (2020)

A cross-sectional study of risk factors and hypertension among adolescent Senior High School students
por: Amponsem-Boateng, Cecilia, et al.
Publicado: (2019)

Engineering T-cells with chimeric antigen receptors to combat hematological cancers: an update on clinical trials
por: Ormhøj, Maria, et al.
Publicado: (2022)

Chimeric Antigen Receptors for T-Cell Malignancies
por: Scherer, Lauren D., et al.
Publicado: (2019)

Hand Hygiene Habits of Ghanaian Youths in Accra
por: Oppong, Timothy B., et al.
Publicado: (2019)

Relapse Mechanism and Treatment Strategy After Chimeric Antigen Receptor T-Cell Therapy in Treating B-Cell Hematological Malignancies
por: Xie, Danni, et al.
Publicado: (2022)

Health Economic Aspects of Chimeric Antigen Receptor T-cell Therapies for Hematological Cancers: Present and Future
por: Heine, Renaud, et al.
Publicado: (2021)

Machine learning-assisted prediction of pneumonia based on non-invasive measures
por: Effah, Clement Yaw, et al.
Publicado: (2022)

Correlates of dietary diversity among children aged 6–23 months of head porters in Ghana
por: Amoah, Adwoa Nyantakyiwaa, et al.
Publicado: (2022)

The current status of nurses–doctors collaboration in clinical decision and its outcome in Tanzania
por: Mboineki, Joanes Faustine, et al.
Publicado: (2019)

Chimeric Antigen Receptor T-cell (CAR T) Therapy for Hematologic and Solid Malignancies: Efficacy and Safety—A Systematic Review with Meta-Analysis
por: Yu, Wen-Liang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lic8cl0c5ctmaohmcgaedvf4fg